Abiopharma

🔍 MAHON PAUL A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 2,690 shares of Common Stock at $146.03 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: false | shares_owned_after: 47,862.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 5,610 shares of Common Stock at $146.03 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: false | shares_owned_after: 53,472.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,690 shares of Common Stock at $524.15 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 50,782.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 502 shares of Common Stock at $520.0331 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 50,280.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,819 shares of Common Stock at $521.0406 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 48,461.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 787 shares of Common Stock at $522.0036 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 47,674.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 850 shares of Common Stock at $522.7838 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 46,824.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 192 shares of Common Stock at $523.6897 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 46,632.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 940 shares of Common Stock at $525.2504 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 45,692.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 400 shares of Common Stock at $526.385 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 45,292.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 120 shares of Common Stock at $527.21 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: false | shares_owned_after: 45,172.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,690 shares of Stock Option at $146.03 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
• Sold 5,610 shares of Stock Option at $146.03 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 64,140.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
• F2: This transaction was executed in multiple trades at prices ranging from $519.33 to $520.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $520.36 to $521.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $521.39 to $522.335. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $522.43 to $523.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $523.45 to $523.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $524.57 to $525.435. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $526.145 to $526.625. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.